Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoo Fukuda

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Dermatology|January 31, 2024
A case of chromomycosis due to Cladosporium halotolerans: Successful identification of previously unreported pathogen with a molecular approachTatsuro Iwasaki, Yurie Shimoda-Komatsu, Yoko Ida, et al.
The Journal of Dermatology|September 9, 2025
Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort StudySaori Takamura, Souichiro Saito, Sora Sugai, et al.
The Journal of Dermatology|December 21, 2022
Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patientsSayaka Takai, Eiichi Arai, Naoko Shojiguchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 28, 2025
A nationwide epidemiological survey of coronavirus disease 2019-associated pulmonary aspergillosis in JapanYuya Ito, Takahiro Takazono, Hotaka Namie, et al.
Japanese Journal of Clinical Oncology|May 3, 2018
Prevalence and molecular characteristics of DNA mismatch repair protein-deficient sebaceous neoplasms and keratoacanthomas in a Japanese hospital-based populationKouki Kuwabara, Okihide Suzuki, Noriyasu Chika, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 1, 2023
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 studyTomoo Fukuda, Keiko Yamagami, Kimito Kawahata, et al.
Allergy and Asthma Proceedings|May 17, 2025
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimabPetra Staubach, Timothy J Craig, Tomoo Fukuda, et al.
The World Allergy Organization Journal|March 6, 2024
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trialDaisuke Honda, Michihiro Hide, Tomoo Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Lynch Syndrome with Muir-Torre Syndrome]Takehiro Shiraishi, Yoshiko Mori, Noriyasu Chika, et al.
The Journal of Dermatology|September 26, 2020
Guidelines for the management of dermatomycosis (2019)Takashi Mochizuki, Ryoji Tsuboi, Ken Iozumi, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Dermatology|January 31, 2024
A case of chromomycosis due to Cladosporium halotolerans: Successful identification of previously unreported pathogen with a molecular approachTatsuro Iwasaki, Yurie Shimoda-Komatsu, Yoko Ida, et al.
The Journal of Dermatology|September 9, 2025
Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort StudySaori Takamura, Souichiro Saito, Sora Sugai, et al.
The Journal of Dermatology|December 21, 2022
Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patientsSayaka Takai, Eiichi Arai, Naoko Shojiguchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 28, 2025
A nationwide epidemiological survey of coronavirus disease 2019-associated pulmonary aspergillosis in JapanYuya Ito, Takahiro Takazono, Hotaka Namie, et al.
Japanese Journal of Clinical Oncology|May 3, 2018
Prevalence and molecular characteristics of DNA mismatch repair protein-deficient sebaceous neoplasms and keratoacanthomas in a Japanese hospital-based populationKouki Kuwabara, Okihide Suzuki, Noriyasu Chika, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 1, 2023
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 studyTomoo Fukuda, Keiko Yamagami, Kimito Kawahata, et al.
Allergy and Asthma Proceedings|May 17, 2025
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimabPetra Staubach, Timothy J Craig, Tomoo Fukuda, et al.
The World Allergy Organization Journal|March 6, 2024
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trialDaisuke Honda, Michihiro Hide, Tomoo Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Lynch Syndrome with Muir-Torre Syndrome]Takehiro Shiraishi, Yoshiko Mori, Noriyasu Chika, et al.
The Journal of Dermatology|September 26, 2020
Guidelines for the management of dermatomycosis (2019)Takashi Mochizuki, Ryoji Tsuboi, Ken Iozumi, et al.
Pageof 4